stockrowDr. Reddy's Laboratories Ltd
RDY Healthcare Drug Manufacturers Specialty & Generic
Dr. Reddy's Laboratories Ltd’s revenue for fiscal 2026 (year ended March 2026) was $3.6 billion, down 6.06% from fiscal 2025.
- Revenue
- −10.1%
- EPS
- −36.8%
- Free cash flow
- −70.5%
- Total debt
- +14.1%
Quarter to September 2026, against a year earlier
Follow RDY
Alert me
Dr. Reddy's Laboratories Ltd (RDY) Book value per share
Dr. Reddy's Laboratories Ltd's book value per share at the end of fiscal 2026 was 4.9×, unchanged from fiscal 2025. At the end of the quarter to 30 September 2026 it was 4.9×. Over the past ten years it has ranged from 2.1× (fiscal 2015) to 4.9× (fiscal 2026) — the current reading is the highest in ten years. Dr. Reddy's Laboratories Ltd ranks 27th of 84 Drug Manufacturers Specialty & Generic companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2026 | 4.9× | 2.77% |
| FY2025 | 4.7× | 17.12% |
| FY2024 | 4.0× | 19.53% |
| FY2023 | 3.4× | 11.81% |
| FY2022 | 3.0× | 6.10% |
| FY2021 | 2.9× | 15.02% |
| FY2020 | 2.5× | 1.53% |
| FY2019 | 2.4× | 4.33% |
| FY2018 | 2.3× | 2.01% |
| FY2017 | 2.3× | 1.07% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 4.9× | (6.45%) |
| Jun 2026 | 5.2× | 7.11% |
| Mar 2026 | 4.9× | (3.06%) |
| Dec 2025 | 5.0× | 2.58% |
| 43 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| NBIX Neurocrine Biosciences, Inc. compare | 38.2× |
| LNTH Lantheus Holdings, Inc. compare | 20.8× |
| ELAN Elanco Animal Health Incorporated compare | 13.2× |
| ALKS Alkermes plc compare | 11.1× |
| KNSA Kiniksa Pharmaceuticals International, plc compare | 9.1× |
| RDY Dr. Reddy's Laboratories Ltd | 4.9× |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | 1.6× |
| HIMS Hims & Hers Health, Inc. compare | 1.4× |
| VTRS Viatris Inc. compare | 0.0× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on RDY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement